ArticleFrontiers in oncology2021

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.

Tian-Hao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.